GlassScriptPhysician profile
Daniel Charles Berman
NPI 1518427244
$7,975.17
in general payments reported to CMS, 2019-2025
13 companies · $6,674 in 2025
The $6,674 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,301 · 2025: $6,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $2,539 · Travel and Lodging: $2,436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $2,538.99 |
| Travel and Lodging | $2,436.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elliquence, LLC | $3,057.28 | 2025 | |
| Alphatec Spine, INC | $2,432.73 | 2024-2025 | Other - Miscellaneous, Identiti, Invictus Open |
| Synthes Gmbh | $716.51 | 2024 | |
| Medtronic, INC. | $714.99 | 2025 | O-Arm, Unid_pass, Cd Horizon Spinal System |
| Globus Medical, INC. | $482.21 | 2024-2025 | Xlif, Modulus, Rise |
| Si-Bone, INC. | $156.77 | 2025 | |
| Depuy Synthes Sales INC. | $137.72 | 2025 | Trialtis |
| Stryker Corporation | $116.67 | 2025 | N/A |
| Myriad Genetic Laboratories, INC. | $46.78 | 2024 | Myrisk |
| Orthofix Medical, INC. | $41.21 | 2025 | Cervical-Stim |
| Vertex Pharmaceuticals Incorporated | $28.59 | 2025 | |
| Convatec INC. | $26.63 | 2025 | |
| Gotham Surgical Solutions & Devices, INC. | $17.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.